See more : Auxly Cannabis Group Inc. (XLY.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Resonate Blends, Inc. (KOAN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Resonate Blends, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Mitie Group plc (MITFF) Income Statement Analysis – Financial Results
- Shimao Services Holdings Limited (0873.HK) Income Statement Analysis – Financial Results
- Wasko S.A. (WAS.WA) Income Statement Analysis – Financial Results
- Guanghe Landscape Culture Communication Co., Ltd. (600234.SS) Income Statement Analysis – Financial Results
- Faith, Inc. (4295.T) Income Statement Analysis – Financial Results
Resonate Blends, Inc. (KOAN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.resonateblends.com
About Resonate Blends, Inc.
Resonate Blends, Inc., a cannabis holding company, provides cannabis-based products. It also operates an online mobile marketing platform that provides various offers, discounts, alerts, and events schedules, such as happy hours, trivia night, and other campaigns. The company was formerly known as Textmunication Holdings, Inc. and changed its name to Resonate Blends, Inc. in December 2019. Resonate Blends, Inc. is based in Calabasas, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.47K | 49.50K | 27.03K | 0.00 | 1.05M | 1.07M | 943.74K | 458.27K | 317.47K | 342.25K | 339.53K | 246.22K | 2.69M | 3.22M | 7.40M | 11.90M | 14.40M | 8.50M | 9.50M | 11.20M | 14.50M | 15.80M | 23.20M | 28.00M | 30.70M | 24.50M | 16.40M |
| Cost of Revenue | 114.14K | 33.07K | 19.15K | 0.00 | 392.67K | 314.64K | 317.34K | 103.09K | 116.34K | 153.76K | 84.06K | 68.80K | 1.15M | 1.84M | 4.97M | 5.04M | 5.00M | 4.22M | 3.45M | 3.50M | 4.80M | 4.90M | 10.30M | 10.90M | 10.80M | 7.80M | 4.90M |
| Gross Profit | -97.67K | 16.43K | 7.88K | 0.00 | 657.49K | 751.77K | 626.40K | 355.19K | 201.13K | 188.50K | 255.47K | 177.43K | 1.55M | 1.39M | 2.43M | 6.87M | 9.41M | 4.29M | 6.06M | 7.70M | 9.70M | 10.90M | 12.90M | 17.10M | 19.90M | 16.70M | 11.50M |
| Gross Profit Ratio | -593.10% | 33.20% | 29.16% | 0.00% | 62.61% | 70.50% | 66.37% | 77.51% | 63.35% | 55.08% | 75.24% | 72.06% | 57.42% | 43.08% | 32.81% | 57.69% | 65.32% | 50.42% | 63.74% | 68.75% | 66.90% | 68.99% | 55.60% | 61.07% | 64.82% | 68.16% | 70.12% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 317.00K | 631.00K | 1.19M | 1.35M | 699.00K | 570.00K | 844.00K | 1.60M | 2.10M | 2.70M | 2.00M | 1.80M | 800.00K | 0.00 | 0.00 |
| General & Administrative | 277.78K | 1.02M | 1.52M | 1.81M | 3.84M | 895.48K | 7.18M | 1.17M | 3.21M | 377.70K | 163.17K | 57.65K | 768.00K | 1.41M | 2.42M | 2.35M | 2.26M | 2.48M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 23.77K | 378.71K | 611.91K | 7.35K | 143.01K | 77.93K | 41.24K | 0.00 | 0.00 | 12.07K | 54.66K | 38.01K | 339.00K | 506.00K | 3.14M | 3.97M | 3.48M | 2.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 301.55K | 1.40M | 2.13M | 1.81M | 3.98M | 973.41K | 7.18M | 1.17M | 3.21M | 426.76K | 346.84K | 200.85K | 1.11M | 1.92M | 5.56M | 6.32M | 5.74M | 4.95M | 6.80M | 6.40M | 9.20M | 8.20M | 16.10M | 17.80M | 17.10M | 12.40M | 8.50M |
| Other Expenses | 0.00 | 7.74K | 405.06K | 605.41K | 24.94K | 255.34K | 37.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 528.00K | 334.00K | 0.00 | 0.00 | 0.00 | 1.62M | 1.70M | 1.70M | 1.60M | 3.40M | 3.00M | 1.60M | 1.20M | 800.00K |
| Operating Expenses | 301.55K | 1.41M | 2.54M | 1.81M | 3.98M | 973.41K | 7.18M | 1.17M | 3.21M | 426.76K | 346.84K | 202.89K | 1.42M | 3.08M | 7.08M | 7.67M | 6.44M | 5.52M | 9.27M | 9.70M | 13.00M | 12.50M | 21.50M | 22.60M | 19.50M | 13.60M | 9.30M |
| Cost & Expenses | 415.69K | 1.44M | 2.56M | 1.81M | 4.37M | 1.29M | 7.49M | 1.27M | 3.32M | 580.52K | 430.90K | 271.68K | 2.57M | 4.91M | 12.06M | 12.70M | 11.43M | 9.74M | 12.71M | 13.20M | 17.80M | 17.40M | 31.80M | 33.50M | 30.30M | 21.40M | 14.20M |
| Interest Income | 0.00 | 181.86K | 392.96K | 111.01K | 195.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 106.00K | 108.00K | 17.00K | 25.00K | 53.00K | 0.00 | 64.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 797.35K | 150.07K | 145.88K | 111.01K | 210.92K | 45.33K | 285.54K | 754.04K | 58.73K | 134.23K | 2.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 200.00K | 100.00K | 0.00 | 0.00 | 100.00K |
| Depreciation & Amortization | 8.81K | 7.74K | 4.71K | 56.35K | 13.13K | 13.13K | 304.00 | 725.00 | 724.00 | 423.00 | -11.65K | 23.42K | 562.00K | 1.13M | 1.82M | 1.66M | 1.48M | 1.74M | 1.62M | 1.70M | 1.70M | 1.60M | 3.40M | 3.00M | 1.60M | 1.20M | 800.00K |
| EBITDA | -609.82K | -1.38M | -4.48M | -1.76M | -3.32M | -306.73K | -7.36M | -2.57M | -3.27M | -237.84K | -91.36K | -2.04K | 685.00K | -448.00K | -3.23M | 423.00K | 4.45M | 503.00K | -1.59M | -300.00K | -1.60M | 700.00K | -5.20M | -2.50M | 2.00M | 4.30M | 3.00M |
| EBITDA Ratio | -3,703.08% | -2,834.93% | -10,237.20% | 0.00% | -317.43% | -19.71% | -694.07% | -173.81% | -1,019.16% | -93.11% | -30.34% | -0.83% | 27.54% | -0.87% | -33.84% | 7.23% | 30.92% | 4.98% | -16.71% | -2.68% | -12.41% | -1.27% | -16.38% | -10.71% | 5.54% | 12.65% | 14.63% |
| Operating Income | -399.22K | -1.39M | -2.53M | -1.81M | -3.32M | -306.73K | -6.55M | -815.62K | -3.01M | -238.26K | -91.36K | -23.42K | 123.00K | -1.69M | -4.66M | -799.00K | 2.97M | -1.24M | -3.21M | -2.00M | -3.30M | -1.60M | -8.60M | -5.50M | 400.00K | 3.10M | 2.20M |
| Operating Income Ratio | -2,424.23% | -2,806.80% | -9,364.82% | 0.00% | -316.37% | -28.76% | -693.92% | -177.98% | -947.32% | -69.62% | -26.91% | -9.51% | 4.57% | -52.30% | -62.91% | -6.71% | 20.63% | -14.55% | -33.76% | -17.86% | -22.76% | -10.13% | -37.07% | -19.64% | 1.30% | 12.65% | 13.41% |
| Total Other Income/Expenses | -1.02M | 2.04M | -2.34M | -143.11K | -347.30K | -33.03K | -1.10M | -2.41M | -547.07K | -218.19K | -20.58K | -2.04K | 49.00K | 108.00K | 17.00K | 25.00K | 53.00K | 23.00K | 64.00K | 0.00 | 300.00K | 200.00K | -1.60M | 600.00K | 300.00K | 1.30M | 600.00K |
| Income Before Tax | -1.42M | 653.63K | -4.87M | -1.96M | -3.67M | 21.00K | -7.65M | -3.26M | -3.55M | -456.45K | -111.95K | -25.46K | 172.00K | -1.58M | -4.64M | -774.00K | 3.03M | -1.21M | -3.14M | 0.00 | -3.00M | -1.40M | -10.20M | -4.90M | 700.00K | 4.40M | 2.80M |
| Income Before Tax Ratio | -8,598.37% | 1,320.43% | -18,027.66% | 0.00% | -349.44% | 1.97% | -810.52% | -711.82% | -1,119.64% | -133.37% | -32.97% | -10.34% | 6.38% | -48.95% | -62.68% | -6.50% | 21.00% | -14.28% | -33.08% | 0.00% | -20.69% | -8.86% | -43.97% | -17.50% | 2.28% | 17.96% | 17.07% |
| Income Tax Expense | 0.00 | -2.21M | 146.57K | 95.21K | 210.92K | 373.06K | 283.82K | 772.44K | 58.73K | 134.23K | 14.22K | -2.04K | -49.00K | 130.00K | -17.00K | 1.00K | 0.00 | 6.00K | 2.85M | 0.00 | 100.00K | 100.00K | -1.10M | -1.80M | 200.00K | 1.50M | -500.00K |
| Net Income | -1.42M | 2.87M | -5.02M | -2.05M | -3.88M | 21.00K | -7.65M | -3.26M | -3.55M | -456.45K | -111.95K | -25.46K | 172.00K | -1.71M | -4.64M | -775.00K | 3.03M | -1.22M | -6.00M | -2.00M | -3.10M | -1.50M | -9.10M | -3.10M | 500.00K | 2.90M | 2.70M |
| Net Income Ratio | -8,598.37% | 5,794.58% | -18,569.87% | 0.00% | -369.53% | 1.97% | -810.52% | -711.82% | -1,119.64% | -133.37% | -32.97% | -10.34% | 6.38% | -52.98% | -62.68% | -6.51% | 21.00% | -14.35% | -63.10% | -17.86% | -21.38% | -9.49% | -39.22% | -11.07% | 1.63% | 11.84% | 16.46% |
| EPS | -0.02 | 0.04 | -0.16 | -0.08 | -0.35 | 0.01 | -3.83 | -24.71 | -43.21 | -6.63 | -1.73 | -0.39 | -193.72 | -3.13K | -8.62K | -1.45K | 6.25K | -2.90K | -14.31K | -5.18K | -9.04K | -4.41K | -27.66K | -9.48K | 1.65K | 10.35K | 7.20K |
| EPS Diluted | -0.02 | 0.04 | -0.16 | -0.08 | -0.35 | 0.01 | -3.83 | -24.71 | -43.21 | -6.63 | -1.73 | -0.39 | -193.72 | -3.13K | -8.62K | -1.45K | 6.25K | -2.90K | -14.31K | -5.18K | -9.04K | -4.41K | -27.66K | -9.48K | 1.65K | 9.90K | 7.20K |
| Weighted Avg Shares Out | 80.01M | 75.44M | 31.09M | 25.46M | 11.24M | 4.22M | 1.99M | 132.01K | 82.26K | 68.83K | 64.84K | 64.51K | 573.00 | 545.00 | 538.00 | 534.00 | 444.00 | 420.00 | 419.00 | 386.00 | 343.00 | 340.00 | 329.00 | 327.00 | 325.00 | 312.00 | 301.00 |
| Weighted Avg Shares Out (Dil) | 80.01M | 75.44M | 31.09M | 25.46M | 11.24M | 4.22M | 1.99M | 132.01K | 82.26K | 68.83K | 64.84K | 64.51K | 573.00 | 545.00 | 538.00 | 534.00 | 444.00 | 420.00 | 419.00 | 386.00 | 343.00 | 340.00 | 329.00 | 327.00 | 325.00 | 312.00 | 301.00 |
Apollo Biowellness, Inc. Announces Joint Venture/Partnership with Reveal Lasers LLC for Expanded Distribution and Collaboration of Evo Bio Products.
North Bergen, New Jersey--(Newsfile Corp. - October 31, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) is pleased to announce a joint venture and distribution partnership with Reveal Lasers LLC to expand the reach of Evolutionary Biologics, Inc.'s biologic products...
Apollo Biowellness, Inc./Evolutionary Biologics, Inc. to feature KOL Dr. David Goldberg, M.D. in Webinar
North Bergen, New Jersey--(Newsfile Corp. - October 29, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) - Evolutionary Biologics is pleased to have Dr. Goldberg as a speaker at EvoBio's webinar on regenerative biologics. With extensive experience in regenerative medicine,...
Apollo Biowellness f/k/a Resonate Blends Announces New Members of the Board of Directors
North Bergen, New Jersey--(Newsfile Corp. - July 30, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) the "Company") is pleased to announce that Jay Lucas and Bobby Carpenter have joined the Board of Directors of the Company. Jay Lucas serves...
Apollo Biowellness f/k/a Resonate Blends Has Engaged LB Equity Health and Wellness Fund, a Division of The Lucas Group
North Bergen, New Jersey--(Newsfile Corp. - July 18, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the "Company") is pleased to announce that it has engaged LB Equity Health and Wellness Fund, a division of The Lucas Group for an...
Apollo Biowellness, Inc./Resonate Blends, Inc., Provides Corporate Update Following Closing of Share Exchange Agreement
North Bergen, New Jersey--(Newsfile Corp. - May 13, 2024) - Apollo Biowellness, Inc., /Resonate Blends, Inc. (OTC Pink: KOAN) ("Resonate Blends" or the "Company") previously completed the Share Exchange Agreement with the holders of certain preferred stock of Emergent Health...
Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
NORTH BERGEN, NJ / ACCESSWIRE / March 15, 2024 / Resonate Blends, Inc. (OTCQB:KOAN) ("Resonate Blends" or the "Company") is pleased to report it has completed a Share Exchange Agreement with the holders of certain preferred stock of Emergent Health...
Resonate Blends Provides an Update on its Acquisition Partner Pegasus Specialty Vehicles
CALABASAS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Resonate Blends, Inc. (OTCQB: KOAN) (“Resonate”) is pleased to report an update on its acquisition partner Pegasus Specialty Vehicles, LLC (“Pegasus” or the “Company”). On June 23, 2023, Resonate announced the signing of an...
Resonate Blends Announces Direct-to-Consumer Delivery Launch of Koan Wellness Cordials
CALABASAS, Calif.--(BUSINESS WIRE)---- $KOAN #balance--Resonate Blends, Inc. (OTCQB:KOAN), a Wellness Lifestyle cannabis holding company ("Resonate" or "the Company") announced today it has launched a direct-to-consumer delivery service of its Koan Cordials, the world's first cannabis, non-alcoholic, single-dose, plant-derived liquids designed...
Resonate Blends Partners with Captor Retail Group to Expand Product Availability Across Major Dispensary Network
CALABASAS, Calif.--(BUSINESS WIRE)---- $KOAN #balance--Resonate Blends, Inc. (OTCQB:KOAN), a Wellness Lifestyle cannabis holding company (“Resonate” or “the Company”), has partnered with Captor Retail Group (“CRG”) to make its Koan Cordials available across CRG's operating dispensaries, including the One Plant California...
Resonate Blends Executes Binding LOI to Acquire a Wellness Cannabis Brand
CALABASAS, Calif.--(BUSINESS WIRE)---- $KOAN #acquisitions--Resonate Blends, Inc. (OTCQB:KOAN), a Wellness Lifestyle cannabis holding company (“Resonate” or “the Company”), signed a binding Letter of Intent (LOI) to acquire all the assets of lemon and grass™ (“the Sellers”). The Seller's products, focused...
Source: https://incomestatements.info
Category: Stock Reports